0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Amniotic Membrane Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-18M14031
Home | Market Reports | Health| Reproductive Health
Global Amniotic Membrane Treatment Market Research Report 2023
BUY CHAPTERS

Amniotic Membrane Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-18M14031
Report
October 2024
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Amniotic Membrane Treatment - Market Size

The global market for Amniotic Membrane Treatment was estimated to be worth US$ 27 million in 2023 and is forecast to a readjusted size of US$ 48 million by 2030 with a CAGR of 8.2% during the forecast period 2024-2030

Amniotic Membrane Treatment - Market

Amniotic Membrane Treatment - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Amniotic Membrane Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Amniotic Membrane Treatment by region & country, by Type, and by Application.
The Amniotic Membrane Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amniotic Membrane Treatment.
Market Segmentation

Scope of Amniotic Membrane Treatment - Market Report

Report Metric Details
Report Name Amniotic Membrane Treatment - Market
Forecasted market size in 2030 US$ 48 million
CAGR 8.2%
Forecasted years 2024 - 2030
Segment by Type:
  • Cryopreserved Amniotic Membrane
  • Lyophilization Amniotic Membrane
Segment by Application
  • Hospitals
  • Specialized Clinics
  • Research Centers & Laboratories
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alliqua BioMedical, Integra LifeSciences, DermaSciences, Katena Products, Applied Biologics, Amnio Technology, Organogensis, TissueTech, Human Regenerative, Osiris Therapeutics, Skye Biologics, Stryker, MiMedx
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Amniotic Membrane Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Amniotic Membrane Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Amniotic Membrane Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Amniotic Membrane Treatment - Market size in 2030?

Ans: The Amniotic Membrane Treatment - Market size in 2030 will be US$ 48 million.

Who are the main players in the Amniotic Membrane Treatment - Market report?

Ans: The main players in the Amniotic Membrane Treatment - Market are Alliqua BioMedical, Integra LifeSciences, DermaSciences, Katena Products, Applied Biologics, Amnio Technology, Organogensis, TissueTech, Human Regenerative, Osiris Therapeutics, Skye Biologics, Stryker, MiMedx

What are the Application segmentation covered in the Amniotic Membrane Treatment - Market report?

Ans: The Applications covered in the Amniotic Membrane Treatment - Market report are Hospitals, Specialized Clinics, Research Centers & Laboratories

What are the Type segmentation covered in the Amniotic Membrane Treatment - Market report?

Ans: The Types covered in the Amniotic Membrane Treatment - Market report are Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane

1 Market Overview
1.1 Amniotic Membrane Treatment Product Introduction
1.2 Global Amniotic Membrane Treatment Market Size Forecast
1.3 Amniotic Membrane Treatment Market Trends & Drivers
1.3.1 Amniotic Membrane Treatment Industry Trends
1.3.2 Amniotic Membrane Treatment Market Drivers & Opportunity
1.3.3 Amniotic Membrane Treatment Market Challenges
1.3.4 Amniotic Membrane Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Amniotic Membrane Treatment Players Revenue Ranking (2023)
2.2 Global Amniotic Membrane Treatment Revenue by Company (2019-2024)
2.3 Key Companies Amniotic Membrane Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Amniotic Membrane Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Amniotic Membrane Treatment
2.6 Amniotic Membrane Treatment Market Competitive Analysis
2.6.1 Amniotic Membrane Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Amniotic Membrane Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amniotic Membrane Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cryopreserved Amniotic Membrane
3.1.2 Lyophilization Amniotic Membrane
3.2 Global Amniotic Membrane Treatment Sales Value by Type
3.2.1 Global Amniotic Membrane Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Amniotic Membrane Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Amniotic Membrane Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialized Clinics
4.1.3 Research Centers & Laboratories
4.2 Global Amniotic Membrane Treatment Sales Value by Application
4.2.1 Global Amniotic Membrane Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Amniotic Membrane Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Amniotic Membrane Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Amniotic Membrane Treatment Sales Value by Region
5.1.1 Global Amniotic Membrane Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Amniotic Membrane Treatment Sales Value by Region (2019-2024)
5.1.3 Global Amniotic Membrane Treatment Sales Value by Region (2025-2030)
5.1.4 Global Amniotic Membrane Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Amniotic Membrane Treatment Sales Value, 2019-2030
5.2.2 North America Amniotic Membrane Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Amniotic Membrane Treatment Sales Value, 2019-2030
5.3.2 Europe Amniotic Membrane Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Amniotic Membrane Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Amniotic Membrane Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Amniotic Membrane Treatment Sales Value, 2019-2030
5.5.2 South America Amniotic Membrane Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Amniotic Membrane Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Amniotic Membrane Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Amniotic Membrane Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Amniotic Membrane Treatment Sales Value
6.3 United States
6.3.1 United States Amniotic Membrane Treatment Sales Value, 2019-2030
6.3.2 United States Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Amniotic Membrane Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Amniotic Membrane Treatment Sales Value, 2019-2030
6.4.2 Europe Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Amniotic Membrane Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Amniotic Membrane Treatment Sales Value, 2019-2030
6.5.2 China Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Amniotic Membrane Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Amniotic Membrane Treatment Sales Value, 2019-2030
6.6.2 Japan Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Amniotic Membrane Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Amniotic Membrane Treatment Sales Value, 2019-2030
6.7.2 South Korea Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Amniotic Membrane Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Amniotic Membrane Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Amniotic Membrane Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Amniotic Membrane Treatment Sales Value, 2019-2030
6.9.2 India Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Amniotic Membrane Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Alliqua BioMedical
7.1.1 Alliqua BioMedical Profile
7.1.2 Alliqua BioMedical Main Business
7.1.3 Alliqua BioMedical Amniotic Membrane Treatment Products, Services and Solutions
7.1.4 Alliqua BioMedical Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Alliqua BioMedical Recent Developments
7.2 Integra LifeSciences
7.2.1 Integra LifeSciences Profile
7.2.2 Integra LifeSciences Main Business
7.2.3 Integra LifeSciences Amniotic Membrane Treatment Products, Services and Solutions
7.2.4 Integra LifeSciences Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Integra LifeSciences Recent Developments
7.3 DermaSciences
7.3.1 DermaSciences Profile
7.3.2 DermaSciences Main Business
7.3.3 DermaSciences Amniotic Membrane Treatment Products, Services and Solutions
7.3.4 DermaSciences Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Katena Products Recent Developments
7.4 Katena Products
7.4.1 Katena Products Profile
7.4.2 Katena Products Main Business
7.4.3 Katena Products Amniotic Membrane Treatment Products, Services and Solutions
7.4.4 Katena Products Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Katena Products Recent Developments
7.5 Applied Biologics
7.5.1 Applied Biologics Profile
7.5.2 Applied Biologics Main Business
7.5.3 Applied Biologics Amniotic Membrane Treatment Products, Services and Solutions
7.5.4 Applied Biologics Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Applied Biologics Recent Developments
7.6 Amnio Technology
7.6.1 Amnio Technology Profile
7.6.2 Amnio Technology Main Business
7.6.3 Amnio Technology Amniotic Membrane Treatment Products, Services and Solutions
7.6.4 Amnio Technology Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Amnio Technology Recent Developments
7.7 Organogensis
7.7.1 Organogensis Profile
7.7.2 Organogensis Main Business
7.7.3 Organogensis Amniotic Membrane Treatment Products, Services and Solutions
7.7.4 Organogensis Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Organogensis Recent Developments
7.8 TissueTech
7.8.1 TissueTech Profile
7.8.2 TissueTech Main Business
7.8.3 TissueTech Amniotic Membrane Treatment Products, Services and Solutions
7.8.4 TissueTech Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 TissueTech Recent Developments
7.9 Human Regenerative
7.9.1 Human Regenerative Profile
7.9.2 Human Regenerative Main Business
7.9.3 Human Regenerative Amniotic Membrane Treatment Products, Services and Solutions
7.9.4 Human Regenerative Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Human Regenerative Recent Developments
7.10 Osiris Therapeutics
7.10.1 Osiris Therapeutics Profile
7.10.2 Osiris Therapeutics Main Business
7.10.3 Osiris Therapeutics Amniotic Membrane Treatment Products, Services and Solutions
7.10.4 Osiris Therapeutics Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Osiris Therapeutics Recent Developments
7.11 Skye Biologics
7.11.1 Skye Biologics Profile
7.11.2 Skye Biologics Main Business
7.11.3 Skye Biologics Amniotic Membrane Treatment Products, Services and Solutions
7.11.4 Skye Biologics Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Skye Biologics Recent Developments
7.12 Stryker
7.12.1 Stryker Profile
7.12.2 Stryker Main Business
7.12.3 Stryker Amniotic Membrane Treatment Products, Services and Solutions
7.12.4 Stryker Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Stryker Recent Developments
7.13 MiMedx
7.13.1 MiMedx Profile
7.13.2 MiMedx Main Business
7.13.3 MiMedx Amniotic Membrane Treatment Products, Services and Solutions
7.13.4 MiMedx Amniotic Membrane Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 MiMedx Recent Developments
8 Industry Chain Analysis
8.1 Amniotic Membrane Treatment Industrial Chain
8.2 Amniotic Membrane Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Amniotic Membrane Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Amniotic Membrane Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Amniotic Membrane Treatment Market Trends
    Table 2. Amniotic Membrane Treatment Market Drivers & Opportunity
    Table 3. Amniotic Membrane Treatment Market Challenges
    Table 4. Amniotic Membrane Treatment Market Restraints
    Table 5. Global Amniotic Membrane Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Amniotic Membrane Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Amniotic Membrane Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Amniotic Membrane Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Amniotic Membrane Treatment
    Table 10. Global Amniotic Membrane Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amniotic Membrane Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Amniotic Membrane Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Amniotic Membrane Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Amniotic Membrane Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Amniotic Membrane Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Amniotic Membrane Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Amniotic Membrane Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Amniotic Membrane Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Amniotic Membrane Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Amniotic Membrane Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Amniotic Membrane Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Amniotic Membrane Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Amniotic Membrane Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Amniotic Membrane Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Amniotic Membrane Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Amniotic Membrane Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Amniotic Membrane Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Amniotic Membrane Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Amniotic Membrane Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Alliqua BioMedical Basic Information List
    Table 32. Alliqua BioMedical Description and Business Overview
    Table 33. Alliqua BioMedical Amniotic Membrane Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Amniotic Membrane Treatment Business of Alliqua BioMedical (2019-2024)
    Table 35. Alliqua BioMedical Recent Developments
    Table 36. Integra LifeSciences Basic Information List
    Table 37. Integra LifeSciences Description and Business Overview
    Table 38. Integra LifeSciences Amniotic Membrane Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Amniotic Membrane Treatment Business of Integra LifeSciences (2019-2024)
    Table 40. Integra LifeSciences Recent Developments
    Table 41. DermaSciences Basic Information List
    Table 42. DermaSciences Description and Business Overview
    Table 43. DermaSciences Amniotic Membrane Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Amniotic Membrane Treatment Business of DermaSciences (2019-2024)
    Table 45. DermaSciences Recent Developments
    Table 46. Katena Products Basic Information List
    Table 47. Katena Products Description and Business Overview
    Table 48. Katena Products Amniotic Membrane Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Amniotic Membrane Treatment Business of Katena Products (2019-2024)
    Table 50. Katena Products Recent Developments
    Table 51. Applied Biologics Basic Information List
    Table 52. Applied Biologics Description and Business Overview
    Table 53. Applied Biologics Amniotic Membrane Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Amniotic Membrane Treatment Business of Applied Biologics (2019-2024)
    Table 55. Applied Biologics Recent Developments
    Table 56. Amnio Technology Basic Information List
    Table 57. Amnio Technology Description and Business Overview
    Table 58. Amnio Technology Amniotic Membrane Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Amniotic Membrane Treatment Business of Amnio Technology (2019-2024)
    Table 60. Amnio Technology Recent Developments
    Table 61. Organogensis Basic Information List
    Table 62. Organogensis Description and Business Overview
    Table 63. Organogensis Amniotic Membrane Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Amniotic Membrane Treatment Business of Organogensis (2019-2024)
    Table 65. Organogensis Recent Developments
    Table 66. TissueTech Basic Information List
    Table 67. TissueTech Description and Business Overview
    Table 68. TissueTech Amniotic Membrane Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Amniotic Membrane Treatment Business of TissueTech (2019-2024)
    Table 70. TissueTech Recent Developments
    Table 71. Human Regenerative Basic Information List
    Table 72. Human Regenerative Description and Business Overview
    Table 73. Human Regenerative Amniotic Membrane Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Amniotic Membrane Treatment Business of Human Regenerative (2019-2024)
    Table 75. Human Regenerative Recent Developments
    Table 76. Osiris Therapeutics Basic Information List
    Table 77. Osiris Therapeutics Description and Business Overview
    Table 78. Osiris Therapeutics Amniotic Membrane Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Amniotic Membrane Treatment Business of Osiris Therapeutics (2019-2024)
    Table 80. Osiris Therapeutics Recent Developments
    Table 81. Skye Biologics Basic Information List
    Table 82. Skye Biologics Description and Business Overview
    Table 83. Skye Biologics Amniotic Membrane Treatment Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Amniotic Membrane Treatment Business of Skye Biologics (2019-2024)
    Table 85. Skye Biologics Recent Developments
    Table 86. Stryker Basic Information List
    Table 87. Stryker Description and Business Overview
    Table 88. Stryker Amniotic Membrane Treatment Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Amniotic Membrane Treatment Business of Stryker (2019-2024)
    Table 90. Stryker Recent Developments
    Table 91. MiMedx Basic Information List
    Table 92. MiMedx Description and Business Overview
    Table 93. MiMedx Amniotic Membrane Treatment Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Amniotic Membrane Treatment Business of MiMedx (2019-2024)
    Table 95. MiMedx Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. Amniotic Membrane Treatment Downstream Customers
    Table 99. Amniotic Membrane Treatment Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Amniotic Membrane Treatment Product Picture
    Figure 2. Global Amniotic Membrane Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Amniotic Membrane Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Amniotic Membrane Treatment Report Years Considered
    Figure 5. Global Amniotic Membrane Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Amniotic Membrane Treatment Revenue in 2023
    Figure 7. Amniotic Membrane Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Cryopreserved Amniotic Membrane Picture
    Figure 9. Lyophilization Amniotic Membrane Picture
    Figure 10. Global Amniotic Membrane Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Amniotic Membrane Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospitals
    Figure 13. Product Picture of Specialized Clinics
    Figure 14. Product Picture of Research Centers & Laboratories
    Figure 15. Global Amniotic Membrane Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Amniotic Membrane Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Amniotic Membrane Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Amniotic Membrane Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Amniotic Membrane Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Amniotic Membrane Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Amniotic Membrane Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Amniotic Membrane Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Amniotic Membrane Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Amniotic Membrane Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Amniotic Membrane Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Amniotic Membrane Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Amniotic Membrane Treatment Sales Value (%), (2019-2030)
    Figure 28. United States Amniotic Membrane Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Amniotic Membrane Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Amniotic Membrane Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Amniotic Membrane Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Amniotic Membrane Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Amniotic Membrane Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Amniotic Membrane Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Amniotic Membrane Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Amniotic Membrane Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Amniotic Membrane Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Amniotic Membrane Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Amniotic Membrane Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Amniotic Membrane Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Amniotic Membrane Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Amniotic Membrane Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 49. Amniotic Membrane Treatment Industrial Chain
    Figure 50. Amniotic Membrane Treatment Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS